Martin Körber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin Körber has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Roland Bodmeier
College of Pharmacy, Freie Universität Berlin, Kelchstrasse 31, 12169 Berlin, Germany
11 shared publications- Roland Bodmeier
College of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany
3 shared publications Zahra Ghalanbor
College of Pharmacy, Freie Universität Berlin, Berlin, Germany
3 shared publicationsJulia Grund
College of Pharmacy, Freie Universität Berlin, Kelchstr. 31, Berlin 12169, Germany
2 shared publications- Luisa F. Duque
College of Pharmacy, Freie Universität Berlin, Kelchstrasse 31, 12169 Berlin, Germany
2 shared publications Marina Kolbina
College of Pharmacy, Freie Universität Berlin, Berlin, Germany
2 shared publications
Latest Publications
- 9 April 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (4) , 159
Evaluation of Hydrogenated Soybean Phosphatidylcholine Matrices Prepared by Hot Melt Extrusion for Oral Controlled Delivery of Water-Soluble Drugs
The aims of this study were to prepare hydrogenated soybean phosphatidylcholine (HSPC) matrices by hot melt extrusion and to evaluate resulting matrix potential to extend drug release in regard to...
- 9 April 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (4) , 159
Evaluation of Hydrogenated Soybean Phosphatidylcholine Matrices Prepared by Hot Melt Extrusion for Oral Controlled Delivery of Water-Soluble Drugs
The aims of this study were to prepare hydrogenated soybean phosphatidylcholine (HSPC) matrices by hot melt extrusion and to evaluate resulting matrix potential to extend drug release in regard to...
- 1 May 2018
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 117, 128-137
Impact of change of matrix crystallinity and polymorphism on ovalbumin release from lipid-based implants
- 1 May 2018
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 117, 128-137
Impact of change of matrix crystallinity and polymorphism on ovalbumin release from lipid-based implants
- 1 March 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 538 (1-2) , 139-146
Improving release completeness from PLGA-based implants for the acid-labile model protein ovalbumin
- 1 March 2018
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 538 (1-2) , 139-146
Improving release completeness from PLGA-based implants for the acid-labile model protein ovalbumin
- 1 October 2017
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 108, 86-92
Saturated phosphatidylcholine as matrix former for oral extended release dosage forms
- 1 October 2017
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 108, 86-92
Saturated phosphatidylcholine as matrix former for oral extended release dosage forms
- 1 July 2014
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 469 (1) , 94-101
The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets
- 1 July 2014
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 469 (1) , 94-101
The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets
- 27 December 2013
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 40 (5) , 619-624
In situforming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies
This study was performed to obtain prolonged drug release with biodegradable in situ forming implants for the local delivery of metronidazole to periodontal pockets. The effect of polymer type (capped and uncapped PLGA), solvent type (water-miscible and water-immiscible) and the polymer/drug ratio on in vitro drug release studies were investigated. In situ implants with sustained metronidazole release and low initial burst consisted of capped PLGA and N-methyl-2-pyrolidone as solvent. Mucoadhesive polymers were incorporated into the in situ implants in order to modify the properties of the delivery systems towards longer residence times in vivo. Addition of the polymers changed the adhesiveness and increased the viscosity and drug release of the formulations. However, sustained drug release over 10 days was achievable. Biodegradable in situ forming implants are therefore an attractive delivery system to achieve prolonged release of metronidazole at periodontal therapy.
- 27 December 2013
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 40 (5) , 619-624
In situforming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies
This study was performed to obtain prolonged drug release with biodegradable in situ forming implants for the local delivery of metronidazole to periodontal pockets. The effect of polymer type (capped and uncapped PLGA), solvent type (water-miscible and water-immiscible) and the polymer/drug ratio on in vitro drug release studies were investigated. In situ implants with sustained metronidazole release and low initial burst consisted of capped PLGA and N-methyl-2-pyrolidone as solvent. Mucoadhesive polymers were incorporated into the in situ implants in order to modify the properties of the delivery systems towards longer residence times in vivo. Addition of the polymers changed the adhesiveness and increased the viscosity and drug release of the formulations. However, sustained drug release over 10 days was achievable. Biodegradable in situ forming implants are therefore an attractive delivery system to achieve prolonged release of metronidazole at periodontal therapy.
- 1 December 2013
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 457 (2) , 503-509
Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile
- 1 December 2013
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 457 (2) , 503-509
Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile
- 1 November 2013
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 85 (3) , 650-655
Predictability of drug release from water-insoluble polymeric matrix tablets
- 1 November 2013
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 85 (3) , 650-655
Predictability of drug release from water-insoluble polymeric matrix tablets
- 1 November 2013
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 85 (3) , 624-630
Interdependency of protein-release completeness and polymer degradation in PLGA-based implants
- 1 November 2013
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 85 (3) , 624-630
Interdependency of protein-release completeness and polymer degradation in PLGA-based implants